Skip to main content
. 2021 Nov 7;49(11):03000605211053549. doi: 10.1177/03000605211053549

Figure 1.

Figure 1.

Artesunate ameliorated neurological deficits and the infarct volume. (a) 2,3,5-Triphenyltetrazolium chloride staining. (b) Infarct volumes of mice at 72 hours after distal middle cerebral artery occlusion (dMCAO) (*P < 0.05 vs the dMCAO group). (c) Rotarod test on the first, second, and third days after dMCAO (*P < 0.05 vs the dMCAO group).